Table 1.

Summary of commonly noted kidney biopsies findings seen with COVID-19

Pathology	Median age (IQR), years	Male/ female (n)	Race/ethnicity breakdowna (%)	SCr (IQR), mg/dLb	Initial presentation (%)	KRT (%)	Alive at discharge (%)
ATI (n = 9)	57.0 (55.0–69.0)	5 M/4 F	AA—22.2 Black—22.2 Hispanic—33.4 White—22.2	4.8 (3.2–6.1)	AKI—77.8 AKI + proteinuria—22.2	Yes—44.4 No—55.5	Alive—66.7 Died—22.2 NA—11.1
CG + ATI (n = 28)	56.0 (46.0–62.7)	18 M/10 F	AA—21.4 African—7.1 Asian—3.6 Black—67.9	6.6 (4.4–10.6)	AKI + NS —67.9 AKI + proteinuria—32.1	Yes—64.2 No—32.1 N/A—3.6	Alive—89.3 Died—7.1 NA—3.6
TMA (n = 3)	45.0 (34.0–69.0)	1 M/2 F	AA—33.3 Hispanic—33.3 White—33.3	7.4 (7.8–11.4)	AKI—33.3 AKI + proteinuria—66.7	Yes—100 No—0	Alive—33.3 Died—66.7
Vasculitis—ANCA and anti-GBM (n = 9)	48.0 (39.5–66.5)	3 M/6 F	AA—22.2 Asian—22.2 Black—11.1 White—44.4	8.2 (4.4–17.8)	AKI—88.9 AKI + proteinuria—11.1	Yes—55.6 No—44.4	Alive—100 Died—0

SCr, serum creatinine; AA, African American; AKI, acute kidney injury; ANCA, antineutrophilic cytoplasmic autoantibody; ATI, acute tubular injury; CG, collapsing glomerulopathy; crt, creatinine; GBM; glomerular basement membrane; NS, nephrotic syndrome; TMA, thrombotic microangiopathy; KRT: kidney replacement therapy. M, Male; F; Female; F, female.

^aRace/ethnicity is cited directly from the source article.

^bSCr values reflect the values of initial presentation.